Genotype–phenotype correlation of congenital anomalies in multiple congenital anomalies hypotonia seizures syndrome (MCAHS1)/PIGN‐related epilepsy

Mutations in PIGN, resulting in multiple congenital anomalies‐hypotonia‐seizures syndrome, a glycosylphosphatidylinositol anchor deficiency, have been published in four families to date. We report four patients from three unrelated families with epilepsy and hypotonia in whom whole exome sequencing yielded compound heterozygous variants in PIGN. As with previous reports Patients 1 and 2 (full siblings) have severe global developmental delay, gastroesophageal reflux disease, and minor dysmorphic features, including high palate, bitemporal narrowing, depressed nasal bridge, and micrognathia; Patient 3 had early global developmental delay with later progressive spastic quadriparesis, intellectual disability, and intractable generalized epilepsy; Patient 4 had bilateral narrowing as well but differed by the presence of hypertelorism, markedly narrow palpebral fissures, and long philtrum, had small distal phalanges of fingers 2, 3, and 4, absent distal phalanx of finger 5 and similar toe anomalies, underdeveloped nails, unusual brain anomalies, and a more severe early clinical course. These patients expand the known clinical spectrum of the disease. The severity of the presentations in conjunction with the patients’ mutations suggest a genotype–phenotype correlation in which congenital anomalies are only seen in patients with biallelic loss‐of‐function. In addition, PIGN mutations appear to be panethnic and may be an underappreciated cause of epilepsy. © 2015 Wiley Periodicals, Inc.

[1]  J. Berg,et al.  The phenotype of multiple congenital anomalies‐hypotonia‐seizures syndrome 1: Report and review , 2015, American journal of medical genetics. Part A.

[2]  C. Ross,et al.  The genotypic and phenotypic spectrum of PIGA deficiency , 2015, Orphanet Journal of Rare Diseases.

[3]  F. Flinter,et al.  Phenotypic features in patients with 15q11.2(BP1‐BP2) deletion: Further delineation of an emerging syndrome , 2014, American journal of medical genetics. Part A.

[4]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[5]  A. Pagnamenta,et al.  Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation. , 2014, American journal of human genetics.

[6]  K. Devriendt,et al.  Exome sequencing identifies a recessive PIGN splice site mutation as a cause of syndromic congenital diaphragmatic hernia. , 2014, European journal of medical genetics.

[7]  Adam J. Schwarz,et al.  CNVs conferring risk of autism or schizophrenia affect cognition in controls , 2013, Nature.

[8]  Jonathan E. Dickerson,et al.  The genetic basis of DOORS syndrome: an exome-sequencing study , 2014, The Lancet Neurology.

[9]  T. Kinoshita,et al.  Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome , 2013, Journal of Medical Genetics.

[10]  Yasuhiro Suzuki,et al.  PIGN mutations cause congenital anomalies, developmental delay, hypotonia, epilepsy, and progressive cerebellar atrophy , 2013, neurogenetics.

[11]  Magalie S Leduc,et al.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.

[12]  Na Zhu,et al.  PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome. , 2013, American journal of human genetics.

[13]  T. Hennet Diseases of glycosylation beyond classical congenital disorders of glycosylation. , 2012, Biochimica et biophysica acta.

[14]  P. Robinson,et al.  Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation. , 2012, American journal of human genetics.

[15]  H. Freeze,et al.  Neurology of inherited glycosylation disorders , 2012, The Lancet Neurology.

[16]  Y. Maeda,et al.  Structural remodeling, trafficking and functions of glycosylphosphatidylinositol-anchored proteins. , 2011, Progress in lipid research.

[17]  G. Rechavi,et al.  Multiple congenital anomalies-hypotonia-seizures syndrome is caused by a mutation in PIGN , 2011, Journal of Medical Genetics.

[18]  S. Schwartz,et al.  Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay , 2011, Human Genetics.

[19]  Sebastian Bauer,et al.  Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome , 2010, Nature Genetics.

[20]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[21]  Y. Jigami,et al.  Lipid remodeling of GPI-anchored proteins and its function. , 2008, Biochimica et biophysica acta.

[22]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[23]  H. Riezman,et al.  Pig-n, a Mammalian Homologue of Yeast Mcd4p, Is Involved in Transferring Phosphoethanolamine to the First Mannose of the Glycosylphosphatidylinositol* , 1999, The Journal of Biological Chemistry.

[24]  S. Reed,et al.  MCD4 encodes a conserved endoplasmic reticulum membrane protein essential for glycosylphosphatidylinositol anchor synthesis in yeast. , 1999, Molecular biology of the cell.

[25]  Samuel F. Berkovic,et al.  Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel ß1 subunit gene SCN1B , 1998, Nature Genetics.

[26]  Douglas C. Wallace,et al.  Radicals r'aging , 1998, Nature Genetics.